WCG
AGN

Weaver Consulting Group’s Allergan plc AGN Stock Holding History

Weaver Consulting Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-71
Closed -$13K – 1046
2020
Q1 		$13K Hold
71
– – 0.01% 411
2019
Q4 		$12K Hold
71
– – 0.01% 458
2019
Q3 		$11K Hold
71
– – 0.01% 470
2019
Q2 		$12K Hold
71
– – 0.01% 428
2019
Q1 		$9K Buy
+71
New +$10.3K ﹤0.01% 981

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Weaver Consulting Group's AGN Position: Q2 2020 in Review

Weaver Consulting Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 71 shares — an estimated $13K sold.

Weaver Consulting Group first reported a position in AGN in Q1 2019 and held it in 5 quarters. The position peaked at $13K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Weaver Consulting Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 71 Allergan plc shares in Q2 2020, an estimated $13K.
  • Weaver Consulting Group first reported a position in Allergan plc in Q1 2019 and held it in 5 quarters.
  • Weaver Consulting Group's Allergan plc position peaked at $13K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Weaver Consulting Group's 13F filing for Q2 2020, filed 24 Jul 2020.